Histamine-mediated signaling processes in human malignant mammary cells

V MEDINA; G CRICCO; M NUÑEZ; G MARTIN, G CRICCO, Z DARVAS, M CROCI, M NUÑEZ, R BERGOC, A FALUS AND E RIVERA; N MOHAMAD; F CORREA- FIZ; F SÁNCHEZ-JIMÉNEZ; R BERGOC; E RIVERA

CANCER BIOLOGY & THERAPY

Landes Bioscience

Lugar: Texas, USA; Año: 2006 vol. 5 p. 1462 - 1471

1538-4047

Histamine is a biogenic amine responsible for multiple biological actions including regulation of physiological functions of mammary gland. It has been postulated that histamine plays a critical role in proliferation of normal and cancer cells. To investigate the biological responses that histamine exerts in malignant cells derived from human mammary gland, we evaluated in MDA-MB-231 line the expression of histamine receptors, histamine intracellular content, the capacity of histamine to influence proliferation, cell cycle progression, differentiation and apoptosis. We also studied histamine involvement in cellular response to ionizing radiation. HBL-100 cells were used as control of nontumorigenic breast cells. Proliferation and surviving fraction were assessed by clonogenic assay. Cell cycle progression and lipid accumulation were determined by flow cytometry while apoptosis was studied by Annexin V and DNA fragmentation assays. Both cell lines expressed the four histamine receptors subtypes as evaluated by western blot and RT-PCR analyses, and present endogenous histamine. Histamine regulated proliferation of cancer cells in a dose-dependent way and 10 µM histamine reduced significantly proliferation to 23% inducing cell cycle arrest in G2/M phase, differentiation by 26% and a significant increase in the number of apoptotic cells (p < 0.01). These responses were not observed in HBL-100 cells. Furthermore, 10 µM histamine exclusively enhanced the radiosensitivity of MDA-MB-231 cells. These results represent the first report about the expression of H3 and H4 receptors in human breast cells. In addition, we conclude that histamine exerts different effects on biological responses of normal and cancer breast cells representing a promising target for the development of more specific and less toxic cancer therapies.